A Role for PGC-1α in Transcription and Excitability of Neocortical and Hippocampal Excitatory Neurons
•Loss of PGC-1α in PNs enhances glutamatergic transmission in the neocortex and hippocampus.•Deletion of PGC-1α from pyramidal neurons (PNs) caused ambulatory hyperactivity in response to a novel environment.•Extent of downregulation in metabolic and neuron-specific transcripts regulated by PGC-1α i...
Gespeichert in:
Veröffentlicht in: | Neuroscience 2020-05, Vol.435, p.73-94 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | •Loss of PGC-1α in PNs enhances glutamatergic transmission in the neocortex and hippocampus.•Deletion of PGC-1α from pyramidal neurons (PNs) caused ambulatory hyperactivity in response to a novel environment.•Extent of downregulation in metabolic and neuron-specific transcripts regulated by PGC-1α in PNs are regionally distinct.
The transcriptional coactivator peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) is a critical regulator of genes involved in neuronal metabolism, neurotransmission, and morphology. Reduced PGC-1α expression has been implicated in several neurological and psychiatric disorders. An understanding of PGC-1α’s roles in different cell types will help determine the functional consequences of PGC-1α dysfunction and/or deficiency in disease. Reports from our laboratory and others suggest a critical role for PGC-1α in inhibitory neurons with high metabolic demand such as fast-spiking interneurons. Here, we document a previously unrecognized role for PGC-1α in maintenance of gene expression programs for synchronous neurotransmitter release, structure, and metabolism in neocortical and hippocampal excitatory neurons. Deletion of PGC-1α from these neurons caused ambulatory hyperactivity in response to a novel environment and enhanced glutamatergic transmission in neocortex and hippocampus, along with reductions in mRNA levels from several PGC-1α neuron-specific target genes. Given the potential role for a reduction in PGC-1α expression or activity in Huntington Disease (HD), we compared reductions in transcripts found in the neocortex and hippocampus of these mice to that of an HD knock-in model; few of these transcripts were reduced in this HD model. These data provide novel insight into the function of PGC-1α in glutamatergic neurons and suggest that it is required for the regulation of structural, neurosecretory, and metabolic genes in both glutamatergic neuron and fast-spiking interneuron populations in a region-specific manner. These findings should be considered when inferring the functional relevance of changes in PGC-1α gene expression in the context of disease. |
---|---|
ISSN: | 0306-4522 1873-7544 |
DOI: | 10.1016/j.neuroscience.2020.03.036 |